The US Food and Drug Administration (FDA) has approved Watson Laboratories' Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.09mg/0.02mg.
Subscribe to our email newsletter
Watson‘s Levonorgestrel and Ethinyl Estradiol Tablets, USP, 0.09mg/0.02mg are the generic version of Lybrel Tablets of Pfizer.
Lybrel is indicated for the prevention of pregnancy in women who choose to use oral contraceptives as a method of contraception.
Lybrel is a progesterone and estrogen combination birth control pill which works by preventing ovulation, thickening the mucus in the cervix and changing the lining of the uterus.